A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
Health The Chatbot-Delusion CrisisHealthradar4. Dezember 2025 submitted by /u/theatlantic [comments] Source link
